Adjuvant (Alliance A021502)
- Result Type
- clinical trial
Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair
Status: Active, Recruiting
8results found for:
Adjuvant (NRG GI005)
- Result Type
- clinical trial
Circulating Tumor DNA Testing in Predicting Treatment for Patients With Stage IIA Colon Cancer After Surgery
Status: Active, Recruiting
City of Hope 96144 Molecular Genetics Studies of Cancer Patients and Their Relatives
- Result Type
- clinical trial
The purpose of this study is to find out how genetics, biologics and behavior might contribute to
Status: Active, Recruiting
Locally Advanced or Metastatic (Krystal-10 Mirati)
- Result Type
- clinical trial
Phase 3 Study of MRTX849 With Cetuximab vs Chemotherapy in Patients With Advanced Colorectal Cancer With KRAS G12C Mutation (KRYSTAL-10)
Metastatic (NRG GI004/SWOG-S1610)
- Result Type
- clinical trial
Combination Chemotherapy, Bevacizumab, and/or Atezolizumab in Treating Patients With Deficient DNA Mismatch Repair Metastatic Colorectal Cancer
Status: Active, Recruiting
Metastatic 1st line (Alliance A021703)
- Result Type
- clinical trial
Vitamin D3 With Chemotherapy and Bevacizumab in Treating Patients With Advanced or Metastatic Colorectal Cancer (SOLARIS)
Status: Active, Recruiting
Targeted Therapy (ASCO TAPUR)
- Result Type
- clinical trial
Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Status: Active, Recruiting
Targeted Therapy (Match EAY131)
- Result Type
- clinical trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, lymphoma, and myeloma
Status: Active, Recruiting